Abstract
Both HIV disease and frailty syndrome are risk factors for neurocognitive impairment. Longitudinal research among individuals of the general population suggests that frailty predicts future cognitive decline; however, there is limited evidence for these longitudinal relationships among people living with HIV (PLWH). The current study evaluated and compared rates of cognitive decline over 2 years among HIV serostatus and frailty status groups. Participants included 50 PLWH and 60 HIV-uninfected (HIV−) participants who were evaluated at baseline and 2-year follow-up visits. Baseline frailty status (non-frail, pre-frail, and frail) was determined using fried frailty phenotype criteria. Neurocognitive functioning was measured using practice-effect corrected scaled scores derived from a comprehensive neuropsychological battery covering seven cognitive domains. Repeated measures analysis was used to estimate rates of global and domain-specific cognitive change from baseline to 2-year follow-up among each of six HIV/frailty status groups. Among PLWH, the pre-frail group demonstrated consistent declines in global cognitive functioning (B = − 0.029, p = 0.034), processing speed (B = − 0.047, p = 0.031), and motor functioning (B = − 0.048, p = 0.038). Among HIV− participants, pre-frail individuals also declined in global cognitive functioning and processing speed (ps ≤ 0.05). HIV− non-frail participants also declined in the cognitive domains of learning, delayed recall, and motor functioning; however, these declines appeared to be driven by relatively higher baseline scores among this group. Notably, 38% of PLWH changed in frailty status from baseline to follow-up, and those with stable pre-frailty demonstrated higher likelihood for cognitive decline; change in depressive symptoms did not relate to change in frailty status. Current findings highlight pre-frailty as an important clinical syndrome that may be predictive of cognitive decline among PLWH. Interventions to prevent or reduce frailty among vulnerable PLWH are needed to maintain optimal cognitive health.
Similar content being viewed by others
References
Afilalo J, Karunananthan S, Eisenberg MJ, Alexander KP, Bergman H (2009) Role of frailty in patients with cardiovascular disease. Am J Cardiol 103:1616–1621
Auyeung TW, Lee JSW, Kwok T, Woo J (2011) Physical frailty predicts future cognitive decline - a four-year prospective study in 2737 cognitively normal older adults. J Nutr Health Aging 15:690–694
Boyle PA, Buchman AS, Barnes LL, Bennett DA (2010a) Effect of a purpose in life on risk of incident Alzheimer disease and mild cognitive impairment in dommunity-dwelling older persons. Arch Gen Psychiatry 67:304–310
Boyle PA, Buchman AS, Wilson RS, Leurgans SE, Bennett DA (2010b) Physical frailty is associated with incident mild cognitive impairment in community-based older persons. J Am Geriatr Soc 58:248–255
Brigola AG, Luchesi BM, Alexandre TDS, Inouye K, Mioshi E, Pavarini SCI (2017) High burden and frailty: association with poor cognitive performance in older caregivers living in rural areas. Trends Psychiatry Psychother 39:257–263
Brigola AG, Rossetti ES, Dos Santos BR, Neri AL, Zazzetta MS, Inouye K, Pavarini SCI (2015) Relationship between cognition and frailty in elderly: a systematic review. Dement Neuropsychol 9:110–119
Brothers TD, Kirkland S, Guaraldi G, Falutz J, Theou O, Johnston BL, Rockwood K (2014) Frailty in people aging with human immunodeficiency virus (HIV) infection. J Infect Dis 210:1170–1179
Buchman AS, Boyle PA, Wilson RS, Tang Y, Bennett DA (2007) Frailty is associated with incident Alzheimer’s disease and cognitive decline in the elderly. Psychosom Med 69:483–489
Bureau, U. S. C. 2018. Older people projected to outnumber children [Online]. US Census Bureau. Available: https://www.census.gov/newsroom/press-releases/2018/cb18-41-population-projections.html [Accessed February 26 2019].
Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK, Group, H (2004) Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26:307–319
Chen XJ, Mao GX, Leng SX (2014) Frailty syndrome: an overview. Clin Interv Aging 9:433–441
Clifford DB, Ances BM (2013) HIV-associated neurocognitive disorder. Lancet Infect Dis 13:976–986
Cody SL, Vance DE (2016) The neurobiology of HIV and its impact on cognitive reserve: a review of cognitive interventions for an aging population. Neurobiol Dis 92:144–156
Cysique LA, Brew BJ (2009) HIV-associated neurocognitive impairment in the context undetectable plasma viral load. J Neurovirol 15:19–19
Deeks SG (2011) HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 62:141–155
Dufour CA, Marquine MJ, Fazeli PL, Henry BL, Ellis RJ, Grant I, Moore DJ, Group, H (2013) Physical exercise is associated with less neurocognitive impairment among HIV-infected adults. J Neurovirol 19:410–417
Erlandson KM, Schrack JA, Jankowski CM, Brown TT, Campbell TB (2014) Functional impairment, disability, and frailty in adults aging with HIV-infection. Curr HIV/AIDS Rep 11:279–290
Farivar SS, Cunningham WE, Hays RD (2007) Correlated physical and mental health summary scores for the SF-36 and SF-12 Health Survey, V.I. Health Qual Life Outcomes 5:54
Ferrucci L, Guralnik JM, Studenski S, Fried LP, Cutler GBJR, Walston JD, Interventions on Frailty Working, G (2004) Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc 52:625–634
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA, Cardiovascular Health Study Collaborative Research, G (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146–M156
Gale CR, Ritchie SJ, Cooper C, Starr JM, Deary IJ (2017) Cognitive ability in late life and onset of physical frailty: the Lothian birth cohort 1936. J Am Geriatr Soc 65:1289–1295
Godin J, Armstrong JJ, Rockwood K, Andrew MK (2017) Dynamics of frailty and cognition after age 50: why it matters that cognitive decline is mostly seen in old age. Journal of Alzheimers Disease 58:231–242
Gray SL, Anderson ML, Hubbard RA, Lacroix A, Crane PK, McCormick W, Bowen JD, McCurry SM, Larson EB (2013) Frailty and incident dementia. J Gerontol Series A Biol Sci Med Sci 68:1083–1090
Greene M, Covinsky KE, Valcour V, Miao Y, Madamba J, Lampiris H, Cenzer IS, Martin J, Deeks SG (2015) Geriatric syndromes in older HIV-infected adults. J Acquir Immune Defic Syndr 69:161–167
Guaraldi G, Ventura P, Albuzza M, Orlando G, Bedini A, Amorico G, Esposito R (2001) Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy. AIDS 15:137–138
Hallal PC, Victora CG (2004) Reliability and validity of the International Physical Activity Questionnaire (IPAQ). Med Sci Sports Exerc 36:556
Harezlak J, Buchthal S, Taylor M, Schifitto G, Zhong JH, Daar E, Alger J, Singer E, Campbell T, Yiannoutsos C, Cohen R, Navia B, Consortium HN (2011) Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. Aids 25:625–633
Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, Group, C (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75:2087–2096
Heaton RK, Franklin DR, Ellis RJ, MCcutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-notestine C, Jernigan TL, Wong J, Grant I, GRP, C. H (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. Journal of Neurovirology 17:3–16
Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, McCutchan JA, Reicks C, Grant I, Group, H (2004a) The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 10:317–331
Heaton RK, Miller SW, Taylor MJ, Grant I (2004b) Revised comprehensive norms for an expanded Halstead-Reitan battery: demographically adjusted neuropsychological norms for African American and Caucasian adults. Lutz, FL, Psychological Assessment Resources
JMP PRO VERSION 12.0.1 (1989-2007) SAS Institute Inc. Cary, NC
Kooij KW, Wit FWNM, Schouten J, van der Valk M, Godfried MH, Stolte IG, Prins M, Falutz J, Reiss P, GRP, A. C. S (2016) HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls. Aids 30:241–250
Lee Y, Kim J, Chon D, Lee KE, Kim JH, Myeong S, Kim S (2018) The effects of frailty and cognitive impairment on 3-year mortality in older adults. Maturitas 107:50–55
McArthur JC, McDermott MP, McClernon D, St Hillaire C, Conant K, Marder K, Schifitto G, Selnes OA, Sacktor N, Stern Y, Albert SM, Kieburtz K, Demarcaida JA, Cohen B, Epstein LG (2004) Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. Arch Neurol 61:1687–1696
Mitnitski A, Fallah N, Rockwood MRH, Rockwood K (2011) Transitions in cognitive status in relation to frailty in older adults: a comparison of three frailty measures. J Nutr Health Aging 15:863–867
Montoya JL, Jankowski CM, O’Brien KK, Webel AR, Oursler KK, Henry BL, Moore DJ, Erlandson KM (2019) Evidence-informed practical recommendations for increasing physical activity among persons living with HIV. AIDS 33:931–939
Moore DJ, Masliah E, Rippeth JD, Gonzalez R, Carey CL, Cherner M, Ellis RJ, Achim CL, Marcotte TD, Heaton RK, Grant I (2006) Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. Aids 20:879–887
Moore RC, Hussain MA, Watson CW, Fazeli PL, Marquine MJ, Yarns BC, Jeste DV, Moore DJ (2018) Grit and ambition are associated with better neurocognitive and everyday functioning among adults living with HIV. AIDS Behav 22:3214–3225
Muthén LK, Muthén BO (1998-2012) Mplus user’s guide. Muthén & Muthén, Los Angeles, CA
Nesselroade J, Stigler S, Baltes P (1980) Regression toward the mean and the study of change. Psychol Bull 88:622
Newman AB, Gottdiener JS, McBurnie MA, Hirsch CH, Kop WJ, Tracy R, Walston JD, Fried LP, Cardiovascular Health Study Research, G (2001) Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci 56:M158–M166
Norman MA, Moore DJ, Taylor M, Franklin D Jr, Cysique L, Ake C, Lazarretto D, Vaida F, Heaton RK, Group, H (2011) Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64-Card Version. J Clin Exp Neuropsychol 33:793–804
Onen NF, Overton ET, Seyfried W, Stumm ER, Snell M, Mondy K, Tebas P (2010) Aging and HIV infection: a comparison between older HIV-infected persons and the general population. Hiv Clinical Trials 11:100–109
Oppenheim H, Paolillo EW, Moore RC, Ellis RJ, Letendre SL, Jeste DV, Grant I, Moore DJ, HIV Neurobehavioral Research Program (2018) Neurocognitive functioning predicts frailty index in HIV. Neurology 91:e162–e170
PREVENTION, C. F. D. C. A. 2018. HIV among people aged 50 and older [Online]. Available: https://www.cdc.gov/hiv/group/age/olderamericans/index.html [Accessed].
Puts MTE, Toubasi S, Andrew MK, Ashe MC, Ploeg J, Atkinson E, Ayala AP, Roy A, Rodriguez Monforte M, Bergman H, McGilton K (2017) Interventions to prevent or reduce the level of frailty in community-dwelling older adults: a scoping review of the literature and international policies. Age Ageing 46:383–392
Puts MTE, Visser M, Twisk JWR, Deeg DJH, Lips P (2005) Endocrine and inflammatory markers as predictors of frailty. Clin Endocrinol 63:403–411
Rabkin JG (2008) HIV and depression: 2008 review and update. Curr HIV/AIDS Rep 5:163–171
Raji MA, Al Snih S, Ostir GV, Markides KS, Ottenbacher KJ (2010) Cognitive status and future risk of frailty in older Mexican Americans. J Gerontol Series A Biol Sci Med Sci 65:1228–1234
Rizzoli R, Reginster JY, Arnal JF, Bautmans I, Beaudart C, Bischoff-Ferrari H, Biver E, Boonen S, Brandi ML, Chines A, Cooper C, Epstein S, Fielding RA, Goodpaster B, Kanis JA, Kaufman JM, Laslop A, Malafarina V, Manas LR, Mitlak BH, Oreffo RO, Petermans J, Reid K, Rolland Y, Sayer AA, Tsouderos Y, Visser M, Bruyere O (2013) Quality of life in sarcopenia and frailty. Calcif Tissue Int 93:101–120
Robertson DA, Savva GM, Coen RF, Kenny RA (2014) Cognitive function in the prefrailty and frailty syndrome. J Am Geriatr Soc 62:2118–2124
Robertson DA, Savva GM, Kenny RA (2013) Frailty and cognitive impairment--a review of the evidence and causal mechanisms. Ageing Res Rev 12:840–851
Rockwood K, Mitnitski A (2007) Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci 62:722–727
Rooney AS, Moore RC, Paolillo EW, Gouaux B, Umlauf A, Letendre SL, Jeste DV, Moore DJ, PROGRAM HIVNR (2019) Depression and aging with HIV: associations with health-related quality of life and positive psychological factors. J Affect Disord 251:1–7
Rubin, L. H., Sundermann, E. E. & Moore, D. J. 2019. The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer’s disease. LID - 10.1007/s13365-018-0702-9 [doi]. Journal of Neurovirology.
Rubtsova, A. A., Marquine, M. J., Depp, C., Holstad, M., Ellis, R. J., Letendre, S., Jeste, D. V. & Moore, D. J. 2018. Psychosocial correlates of frailty among HIV-infected and HIV-uninfected adults. Behav Med, 1-11.
Slaets JP (2006) Vulnerability in the elderly: frailty. Med Clin North Am 90:593–601
Smit M, Brinkman K, Geerlings S, Smit C, Thyagarajan K, Sighem A, de Wolf F, Hallett TB, Cohort AO (2015) Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis 15:810–818
Soysal P, Veronese N, Thompson T, Kahl KG, Fernandes BS, Prina AM, Solmi M, Schofield P, Koyanagi A, Tseng PT, Lin PY, Chu CS, Cosco TD, Cesari M, Carvalho AF, Stubbs B (2017) Relationship between depression and frailty in older adults: a systematic review and meta-analysis. Ageing Res Rev 36:78–87
Valcour V, SHikuma C, Shiramizu B, Watters M, Poff P, Selnes O, Holck P, Grove J, Sacktor N (2004) Higher frequency of dementia in older HIV-1 individuals: the Hawaii aging with HIV-1 cohort. Neurology 63:822–827
Vaughan L, Corbin AL, Goveas JS (2015) Depression and frailty in later life: a systematic review. Clin Interv Aging 10:1947–1958
Wallace LMK, Ferrara M, Brothers TD, Garlassi S, Kirkland SA, Theou O, Zona S, Mussini C, Moore D, Rockwood K, Guaraldi G (2017) Lower frailty is associated with successful cognitive aging among older adults with HIV. Aids Research and Human Retroviruses 33:157–163
Wallace LMK, Theou O, Godin J, Andrew MK, Bennett DA, Rockwood K (2019) Investigation of frailty as a moderator of the relationship between neuropathology and dementia in Alzheimer’s disease: a cross-sectional analysis of data from the Rush Memory and Aging Project. Lancet Neurol 18:177–184
World Health Organization (1998) Composite Diagnositic International Interview (CIDI, version 2.1). World Health Organization, Geneva, Switzerland
Acknowledgments
The San Diego HIV Neurobehavioral Research Center [HNRC] group is affiliated with the University of California, San Diego, the Naval Hospital, San Diego, and the Veterans Affairs San Diego Healthcare System, and includes: Director: Robert K. Heaton, Ph.D., Co-Director: Igor Grant, M.D.; Associate Directors: J. Hampton Atkinson, M.D., Ronald J. Ellis, M.D., Ph.D., and Scott Letendre, M.D.; Center Manager: Thomas D. Marcotte, Ph.D.; Jennifer Marquie-Beck, M.P.H.; Melanie Sherman; Neuromedical Component: Ronald J. Ellis, M.D., Ph.D. (P.I.), Scott Letendre, M.D., J. Allen McCutchan, M.D., Brookie Best, Pharm.D., Rachel Schrier, Ph.D., Debra Rosario, M.P.H.; Neurobehavioral Component: Robert K. Heaton, Ph.D. (P.I.), J. Hampton Atkinson, M.D., Steven Paul Woods, Psy.D., Thomas D. Marcotte, Ph.D., Mariana Cherner, Ph.D., David J. Moore, Ph.D., Matthew Dawson; Neuroimaging Component: Christine Fennema-Notestine, Ph.D. (P.I.), Monte S. Buchsbaum, M.D., John Hesselink, M.D., Sarah L. Archibald, M.A., Gregory Brown, Ph.D., Richard Buxton, Ph.D., Anders Dale, Ph.D., Thomas Liu, Ph.D.; Neurobiology Component: Eliezer Masliah, M.D. (P.I.), Cristian Achim, M.D., Ph.D.; Neurovirology Component: David M. Smith, M.D. (P.I.), Douglas Richman, M.D.; International Component: J. Allen McCutchan, M.D., (P.I.), Mariana Cherner, Ph.D.; Developmental Component: Cristian Achim, M.D., Ph.D.; (P.I.), Stuart Lipton, M.D., Ph.D.; Participant Accrual and Retention Unit: J. Hampton Atkinson, M.D. (P.I.), Jennifer Marquie-Beck, M.P.H.; Data Management and Information Systems Unit: Anthony C. Gamst, Ph.D. (P.I.), Clint Cushman; Statistics Unit: Ian Abramson, Ph.D. (P.I.), Florin Vaida, Ph.D. (Co-PI), Anya Umlauf, M.S., Bin Tang, Ph.D.
Funding
This research was supported by the National Institute of Mental Health (grant numbers R01MH099987, P30MH062512, R25MH081482 (stipend support to ECP)), the National Institute on Alcohol Abuse and Alcoholism (grant number F31 AA027198 (stipend support to EWP)), and the National Institute on Drug Abuse (grant number T32 DA031098 (stipend support to NSS)).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All study procedures were approved by the UCSD Institutional Review Board. All participants were English-speaking and provided written informed consent.
Disclaimer
The views expressed in this article are those of the authors and do not reflect the official policy or position of the Department of the Navy, Department of Defense, nor the US Government.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Paolillo, E.W., Sun-Suslow, N., Pasipanodya, E.C. et al. Pre-frailty predicts cognitive decline at 2-year follow-up in persons living with HIV. J. Neurovirol. 26, 168–180 (2020). https://doi.org/10.1007/s13365-019-00814-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13365-019-00814-2